Abstract
The secretion of interferon-gamma (IFN-gamma) by natural killer (NK) cells following in vitro stimulation with interleukin-2 (IL-2) is inhibited by co-incubation with autologous monocytes at a transcriptional level by more than sixty-fold. In this study, we investigate the nature of the inhibitory signal and particularly the role of reactive oxygen metabolites (ROMs). It was found that the inhibition of IFN-gamma was operating at a pre-translational level, this was indicated by the inability of CD 56(+)-enriched natural killer cells to accumulate IFN-gamma mRNA in the presence of elutriated monocytes. Both catalase, a scavenger of hydrogen peroxide and histamine, a biogenic amine which inhibits the generation of ROMs by monocytes, strongly abrogated the inhibition of IFN-gamma production. We thereby conclude that histamine behaves synergistically with IL-2 at a transcriptional level to induce IFN-gamma even in an admixture of NK cells and monocytes.
Citations
Aug 26, 2014·Neural Computation·Beatrice A GolombJanis B Ritchie
Apr 27, 2013·International Reviews of Immunology·Yuhui YangSvetlana Karakhanova
Dec 1, 2001·Expert Opinion on Biological Therapy·S S Agarwala, M H Sabbagh
Mar 4, 2014·PloS One·Ali A AkhianiFredrik B Thorén
Mar 25, 2004·Journal of Leukocyte Biology·Asa BettenKristoffer Hellstrand
Sep 17, 2004·Journal of Leukocyte Biology·Fredrik ThorénKristoffer Hellstrand
Sep 14, 2004·Journal of Leukocyte Biology·Markus HanssonKristoffer Hellstrand
Apr 21, 2016·Oncotarget·Olle WerleniusFredrik B Thorén
Oct 23, 2016·Oncotarget·Caroline JochemsKwong Y Tsang
Jul 21, 2009·Journal of Internal Medicine·T Sutlu, E Alici
Aug 26, 2009·Scandinavian Journal of Immunology·A I RomeroK Hellstrand
Sep 4, 2015·Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society·Shoko KimuraNoriko Murase
Dec 17, 2015·The Journal of Biological Chemistry·Matthew S J ManganPhillip I Bird
Dec 3, 2005·Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences·Wulf Dröge
Apr 20, 2001·British Journal of Pharmacology·J K CallawayS F Giardina